OPK
Opko Health, Inc.Price & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OPK
this stock
Opko Health, Inc.
|
$898.56M | -5.6% | -14.0% | — | 4.3% |
|
TMO
Thermo Fisher Scientific Inc.
|
$197.88B | -6.2% | +0.4% | 29.3 | 1.4% |
|
DHR
Danaher Corp /De/
|
$145.10B | -10.1% | +8.5% | 39.6 | 1.5% |
|
IDXX
Idexx Laboratories Inc /De
|
$44.76B | -14.8% | +10.4% | 41.8 | 2.5% |
|
NTRA
Natera, Inc.
|
$38.87B | +17.8% | -2.8% | — | 4.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OPK | -14.4% | -14.4% | -12.5% | -20.7% | -5.6% |
| SPY | -0.1% | +0.1% | +9.0% | +0.5% | +10.1% |
| vs SPY | -14.3% | -14.4% | -21.5% | -21.2% | -15.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.